YERVOY™ (ipilimumab) approved for the treatment of previously-treated advanced melanoma in the EU
14 July 2011 | By Bristol-Myers Squibb
The European Commission has approved YERVOY™ (ipilimumab)...
List view / Grid view
14 July 2011 | By Bristol-Myers Squibb
The European Commission has approved YERVOY™ (ipilimumab)...
21 June 2011 | By Eli Lilly and Company
Eli Lilly and Company, together with Amylin Pharmaceuticals, Inc. and Alkermes, Inc., announced that the European Commission has granted marketing authorization to BYDUREON™...
7 June 2011 | By Biogen Idec
Biogen Idec announced that the European Commission has granted approval to AVONEX PEN...
6 June 2011 | By Novartis
The European Commission has granted Novartis a new indication for Lucentis® (ranibizumab)...
20 May 2011 | By Bristol-Myers Squibb Company
The European Commission has approved ELIQUIS® in the 27 countries of the EU...
5 May 2011 | By Pfizer
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission...
21 March 2011 | By Novartis
The European Commission has granted Novartis approval for Gilenya®...
9 March 2011 | By Resolute Communications
XEPLION®, has received approval from the European Commission for the treatment of schizophrenia...
2 March 2011 | By Roche
Avastin in combination with paclitaxel will remain a treatment option for women with metastatic breast cancer in Europe...